Here we review viral and cellular requirements for entry and intracellular trafficking of foamy viruses (FVs) resulting in integration of viral sequences into the host cell genome. The virus encoded glycoprotein harbors all essential viral determinants, which are involved in absorption to the host membrane and triggering the uptake of virus particles. However, only recently light was shed on some details of FV’s interaction with its host cell receptor(s). Latest studies indicate glycosaminoglycans of cellular proteoglycans, particularly heparan sulfate, to be of utmost importance. In a species-specific manner FVs encounter endogenous machineries of the target cell, which are in some cases exploited for fusion and further egress into the cytosol. Mostly triggered by pH-dependent endocytosis, viral and cellular membranes fuse and release naked FV capsids into the cytoplasm. Intact FV capsids are then shuttled along microtubules and are found to accumulate nearby the centrosome where they can remain in a latent state for extended time periods. Depending on the host cell cycle status, FV capsids finally disassemble and, by still poorly characterized mechanisms, the preintegration complex gets access to the host cell chromatin. Host cell mitosis finally allows for viral genome integration, ultimately starting a new round of viral replication.
References
[1]
Hill, C.L.; Bieniasz, P.D.; McClure, M.O. Properties of human foamy virus relevant to its development as a vector for gene therapy. J. Gen. Virol. 1999, 80, 2003–2009.
[2]
Mergia, A.; Leung, N.J.; Blackwell, J. Cell tropism of the simian foamy virus type 1 (SFV-1). J. Med. Primatol. 1996, 25, 2–7, doi:10.1111/j.1600-0684.1996.tb00185.x.
[3]
Russell, D.W.; Miller, A.D. Foamy virus vectors. J. Virol. 1996, 70, 217–222.
[4]
Lindemann, D.; Pietschmann, T.; Picard-Maureau, M.; Berg, A.; Heinkelein, M.; Thurow, J.; Knaus, P.; Zentgraf, H.; Rethwilm, A. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J. Virol. 2001, 75, 5762–5771, doi:10.1128/JVI.75.13.5762-5771.2001.
[5]
Wilk, T.; de Haas, F.; Wagner, A.; Rutten, T.; Fuller, S.; Flügel, R.M.; L？chelt, M. The intact retroviral Env glycoprotein of human foamy virus is a trimer. J. Virol. 2000, 74, 2885–2887, doi:10.1128/JVI.74.6.2885-2887.2000.
[6]
Nasimuzzaman, M.; Persons, D.A. Cell membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells. Mol. Ther. 2012, 20, 1158–1166, doi:10.1038/mt.2012.41.
[7]
Plochmann, K.; Horn, A.; Gschmack, E.; Armbruster, N.; Krieg, J.; Wiktorowicz, T.; Weber, C.; Stirnnagel, K.; Lindemann, D.; Rethwilm, A.; et al. Heparan sulfate is an attachment factor for foamy virus entry. J. Virol. 2012, 86, 10028–10035, doi:10.1128/JVI.00051-12.
Lee, E.G.; Stenbak, C.R.; Linial, M.L. Foamy virus assembly with emphasis on pol encapsidation. Viruses 2013, 5, 886–900, doi:10.3390/v5030886.
[10]
Hütter, S.; Zurnic, I.; Lindemann, D. Foamy virus budding and release. Viruses 2013, 5. submitted.
[11]
Lehmann-Che, J.; Renault, N.; Giron, M.L.; Roingeard, P.; Clave, E.; Tobaly-Tapiero, J.; Bittoun, P.; Toubert, A.; de The, H.; Saib, A. Centrosomal latency of incoming foamy viruses in resting cells. PLoS Pathog. 2007, 3, e74, doi:10.1371/journal.ppat.0030074.
[12]
Petit, C.; Giron, M.L.; Tobaly-Tapiero, J.; Bittoun, P.; Real, E.; Jacob, Y.; Tordo, N.; de The, H.; Saib, A. Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8. J. Cell Sci. 2003, 116, 3433–3442, doi:10.1242/jcs.00613.
[13]
Saib, A.; Puvion Dutilleul, F.; Schmid, M.; Peries, J.; de The, H. Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J. Virol. 1997, 71, 1155–1161.
Hütter, S.; Müllers, E.; Stanke, N.; Reh, J.; Lindemann, D. Prototype Foamy Virus protease activity is essential for intra-particle reverse transcription initiation but not absolutely required for uncoating upon host cell entry. J. Virol. 2013. in press.
[16]
Lehmann-Che, J.; Giron, M.L.; Delelis, O.; Lochelt, M.; Bittoun, P.; Tobaly-Tapiero, J.; de The, H.; Saib, A. Protease-dependent uncoating of a complex retrovirus. J. Virol. 2005, 79, 9244–9253, doi:10.1128/JVI.79.14.9244-9253.2005.
[17]
Bieniasz, P.D.; Weiss, R.A.; McClure, M.O. Cell cycle dependence of foamy retrovirus infection. J. Virol. 1995, 69, 7295–7299.
[18]
Lo, Y.T.; Tian, T.; Nadeau, P.E.; Park, J.; Mergia, A. The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus. J. Virol. 2010, 84, 2832–2842, doi:10.1128/JVI.02435-09.
[19]
Trobridge, G.; Russell, D.W. Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J. Virol. 2004, 78, 2327–2335, doi:10.1128/JVI.78.5.2327-2335.2004.
[20]
Nethe, M.; Berkhout, B.; van der Kuyl, A.C. Retroviral superinfection resistance. Retrovirology 2005, 2, e52.
[21]
Sommerfelt, M.A.; Weiss, R.A. Receptor interference groups of 20 retroviruses plating on human cells. Virology 1990, 176, 58–69, doi:10.1016/0042-6822(90)90230-O.
[22]
Moebes, A.; Enssle, J.; Bieniasz, P.D.; Heinkelein, M.; Lindemann, D.; Bock, M.; McClure, M.O.; Rethwilm, A. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J. Virol. 1997, 71, 7305–7311.
[23]
Berg, A.; Pietschmann, T.; Rethwilm, A.; Lindemann, D. Determinants of foamy virus envelope glycoprotein mediated resistance to superinfection. Virology 2003, 314, 243–252, doi:10.1016/S0042-6822(03)00401-X.
[24]
Herchenr？der, O.; Moosmayer, D.; Bock, M.; Pietschmann, T.; Rethwilm, A.; Bieniasz, P.D.; McClure, M.O.; Weis, R.; Schneider, J. Specific binding of recombinant foamy virus envelope protein to host cells correlates with susceptibility to infection. Virology 1999, 255, 228–236, doi:10.1006/viro.1998.9570.
[25]
Duda, A.; Luftenegger, D.; Pietschmann, T.; Lindemann, D. Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain. J. Virol. 2006, 80, 8158–8167, doi:10.1128/JVI.00460-06.
[26]
Hunter, E. Viral Entry and Receptors. In Retroviruses; Coffin, J.M., Hughes, S.H., Varmus, H.E., Eds.; Cold Spring Harbor Laboratory Press: Plainview, NY, USA, 1997.
[27]
Battini, J.L.; Danos, O.; Heard, J.M. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J. Virol. 1995, 69, 713–719.
[28]
Davey, R.A.; Hamson, C.A.; Healey, J.J.; Cunningham, J.M. In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1. J. Virol. 1997, 71, 8096–8102.
[29]
Heard, J.M.; Danos, O. An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J. Virol. 1991, 65, 4026–4032.
[30]
Kowalski, M.; Potz, J.; Basiripour, L.; Dorfman, T.; Goh, W.C.; Terwilliger, E.; Dayton, A.; Rosen, C.; Haseltine, W.; Sodroski, J. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 1987, 237, 1351–1355.
[31]
Nygren, A.; Bergman, T.; Matthews, T.; Jornvall, H.; Wigzell, H. 95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor. Proc. Natl. Acad. Sci. USA 1988, 85, 6543–6546, doi:10.1073/pnas.85.17.6543.
Lüftenegger, D.; Picard-Maureau, M.; Stanke, N.; Rethwilm, A.; Lindemann, D. Analysis and function of prototype foamy virus envelope N glycosylation. J. Virol. 2005, 79, 7664–7672, doi:10.1128/JVI.79.12.7664-7672.2005.
[34]
Vigerust, D.J.; Shepherd, V.L. Virus glycosylation: Role in virulence and immune interactions. Trends Microbiol. 2007, 15, 211–218, doi:10.1016/j.tim.2007.03.003.
[35]
Krey, T.; d'Alayer, J.; Kikuti, C.M.; Saulnier, A.; Damier-Piolle, L.; Petitpas, I.; Johansson, D.X.; Tawar, R.G.; Baron, B.; Robert, B.; et al. The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS Pathog. 2010, 6, e1000762, doi:10.1371/journal.ppat.1000762.
[36]
Wahid, A.; Helle, F.; Descamps, V.; Duverlie, G.; Penin, F.; Dubuisson, J. Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein. J. Virol. 2013, 87, 1605–1617, doi:10.1128/JVI.02659-12.
[37]
McCaffrey, K.; Boo, I.; Tewierek, K.; Edmunds, M.L.; Poumbourios, P.; Drummer, H.E. Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function. J. Virol. 2012, 86, 3961–3974, doi:10.1128/JVI.05396-11.
[38]
Mergia, A.; Shaw, K.E.; Lackner, J.E.; Luciw, P.A. Relationship of the env genes and the endonuclease domain of the pol genes of simian foamy virus type 1 and human foamy virus. J. Virol. 1990, 64, 406–410.
[39]
Crooks, G.M.; Kohn, D.B. Growth factors increase amphotropic retrovirus binding to human CD34+ bone marrow progenitor cells. Blood 1993, 82, 3290–3297.
[40]
Liu, J.; Thorp, S.C. Cell surface heparan sulfate and its roles in assisting viral infections. Med. Res. Rev. 2002, 22, 1–25, doi:10.1002/med.1026.
[41]
Peisajovich, S.G.; Shai, Y. High similarity between reverse-oriented sequences from HIV and foamy virus envelope glycoproteins. AIDS Res. Hum. Retrovir. 2002, 18, 309–312, doi:10.1089/088922202753472883.
[42]
Wang, G.; Mulligan, M.J. Comparative sequence analysis and predictions for the envelope glycoproteins of foamy viruses. J. Gen. Virol. 1999, 80, 245–254.
[43]
Pietschmann, T.; Zentgraf, H.; Rethwilm, A.; Lindemann, D. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. J. Virol. 2000, 74, 4474–4482, doi:10.1128/JVI.74.10.4474-4482.2000.
[44]
Bansal, A.; Shaw, K.L.; Edwards, B.H.; Goepfert, P.A.; Mulligan, M.J. Characterization of the R572T point mutant of a putative cleavage site in human foamy virus Env. J. Virol. 2000, 74, 2949–2954, doi:10.1128/JVI.74.6.2949-2954.2000.
[45]
Duda, A.; Stange, A.; Luftenegger, D.; Stanke, N.; Westphal, D.; Pietschmann, T.; Eastman, S.W.; Linial, M.L.; Rethwilm, A.; Lindemann, D. Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity. J. Virol. 2004, 78, 13865–13870, doi:10.1128/JVI.78.24.13865-13870.2004.
[46]
Geiselhart, V.; Bastone, P.; Kempf, T.; Schnolzer, M.; L？chelt, M. Furin-mediated cleavage of the feline foamy virus Env leader protein. J. Virol. 2004, 78, 13573–13581, doi:10.1128/JVI.78.24.13573-13581.2004.
[47]
Picard-Maureau, M.; Jarmy, G.; Berg, A.; Rethwilm, A.; Lindemann, D. Foamy virus envelope glycoprotein-mediated entry involves a pH-Dependent fusion process. J. Virol. 2003, 77, 4722–4730, doi:10.1128/JVI.77.8.4722-4730.2003.
[48]
Radtke, K.; Dohner, K.; Sodeik, B. Viral interactions with the cytoskeleton: A hitchhiker’s guide to the cell. Cell Microbiol. 2006, 8, 387–400, doi:10.1111/j.1462-5822.2005.00679.x.
[49]
Fischer, N.; Heinkelein, M.; Lindemann, D.; Enssle, J.; Baum, C.; Werder, E.; Zentgraf, H.; Müller, J.G.; Rethwilm, A. Foamy virus particle formation. J. Virol. 1998, 72, 1610–1615.
[50]
Schliephake, A.W.; Rethwilm, A. Nuclear localization of foamy virus Gag precursor protein. J. Virol. 1994, 68, 4946–4954.
[51]
Vale, R.D. The molecular motor toolbox for intracellular transport. Cell 2003, 112, 467–480, doi:10.1016/S0092-8674(03)00111-9.
[52]
Schliwa, M.; Woehlke, G. Molecular motors. Nature 2003, 422, 759–765, doi:10.1038/nature01601.
[53]
Giron, M.L.; Colas, S.; Wybier, J.; Rozain, F.; Emanoil Ravier, R. Expression and maturation of human foamy virus Gag precursor polypeptides. J. Virol. 1997, 71, 1635–1639.
[54]
Stolp, B.; Fackler, O.T. How HIV takes advantage of the cytoskeleton in entry and replication. Viruses 2011, 3, 293–311, doi:10.3390/v3040293.
[55]
Imrich, H.; Heinkelein, M.; Herchenroder, O.; Rethwilm, A. Primate foamy virus Pol proteins are imported into the nucleus. J. Gen. Virol. 2000, 81, 2941–2947.
An, D.G.; Hyun, U.; Shin, C.G. Characterization of nuclear localization signals of the prototype foamy virus integrase. J. Gen. Virol. 2008, 89, 1680–1684.
[58]
Tobaly-Tapiero, J.; Bittoun, P.; Lehmann-Che, J.; Delelis, O.; Giron, M.L.; de The, H.; Saib, A. Chromatin tethering of incoming foamy virus by the structural Gag protein. Traffic 2008, 9, 1717–1727, doi:10.1111/j.1600-0854.2008.00792.x.
[59]
Yu, S.F.; Edelmann, K.; Strong, R.K.; Moebes, A.; Rethwilm, A.; Linial, M.L. The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J. Virol. 1996, 70, 8255–8262.
[60]
Mullers, E.; Stirnnagel, K.; Kaulfuss, S.; Lindemann, D. Prototype Foamy virus gag nuclear localization: A novel pathway among retroviruses. J. Virol. 2011, 85, 9276–9285, doi:10.1128/JVI.00663-11.
[61]
Stenbak, C.R.; Linial, M.L. Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression. J. Virol. 2004, 78, 9423–9430, doi:10.1128/JVI.78.17.9423-9430.2004.
[62]
Müllers, E.; Uhlig, T.; Stirnnagel, K.; Fiebig, U.; Zentgraf, H.; Lindemann, D. Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis. J. Virol. 2011, 85, 1452–1463, doi:10.1128/JVI.01731-10.
[63]
Fassati, A. Multiple roles of the capsid protein in the early steps of HIV-1 infection. Virus Res. 2012, 170, 15–24, doi:10.1016/j.virusres.2012.09.012.
[64]
Arhel, N. Revisiting HIV-1 uncoating. Retrovirology 2010, 7, e96, doi:10.1186/1742-4690-7-96.
[65]
Yu, S.F.; Baldwin, D.N.; Gwynn, S.R.; Yendapalli, S.; Linial, M.L. Human foamy virus replication: A pathway distinct from that of retroviruses and hepadnaviruses. Science 1996, 271, 1579–1582.
[66]
Zamborlini, A.; Renault, N.; Saib, A.; Delelis, O. Early reverse transcription is essential for productive foamy virus infection. PLoS One 2010, 5, e11023, doi:10.1371/journal.pone.0011023.
[67]
Delelis, O.; Saib, A.; Sonigo, P. Biphasic DNA synthesis in spumaviruses. J. Virol. 2003, 77, 8141–8146, doi:10.1128/JVI.77.14.8141-8146.2003.
[68]
Pfrepper, K.I.; L？chelt, M.; Rackwitz, H.R.; Schnolzer, M.; Heid, H.; Flügel, R.M. Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus. J. Virol. 1999, 73, 7907–7911.
Murray, S.M.; Picker, L.J.; Axthelm, M.K.; Hudkins, K.; Alpers, C.E.; Linial, M.L. Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections. J. Virol. 2008, 82, 5981–5985, doi:10.1128/JVI.00367-08.
[71]
Iwasaki, A. Innate immune recognition of HIV-1. Immunity 2012, 37, 389–398, doi:10.1016/j.immuni.2012.08.011.
[72]
Ploquin, M.J.; Jacquelin, B.; Jochems, S.P.; Barre-Sinoussi, F.; Muller-Trutwin, M.C. Innate immunity in the control of HIV/AIDS: Recent advances and open questions. AIDS 2012, 26, 1269–1279, doi:10.1097/QAD.0b013e328353e46b.
[73]
Colas, S.; Bourge, J.F.; Wybier, J.; Chelbi Alix, M.K.; Paul, P.; Emanoil Ravier, R. Human foamy virus infection activates class I major histocompatibility complex antigen expression. J. Gen. Virol. 1995, 76, 661–667, doi:10.1099/0022-1317-76-3-661.
[74]
Rhodes-Feuillette, A.; Saal, F.; Lasneret, J.; Santillana-Hayat, M.; Peries, J. Studies on in vitro interferon induction capacity and interferon sensitivity of simian foamy viruses. Arch. Virol. 1987, 97, 77–84, doi:10.1007/BF01310735.
[75]
Sabile, A.; Rhodes Feuillette, A.; Jaoui, F.Z.; Tobaly Tapiero, J.; Giron, M.L.; Lasneret, J.; Peries, J.; Canivet, M. In vitro studies on interferon-inducing capacity and sensitivity to IFN of human foamy virus. Res. Virol. 1996, 147, 29–37, doi:10.1016/0923-2516(96)80237-8.
[76]
Rua, R.; Lepelley, A.; Gessain, A.; Schwartz, O. Innate sensing of foamy viruses by human hematopoietic cells. J. Virol. 2012, 86, 909–918, doi:10.1128/JVI.06235-11.
[77]
Meiering, C.D.; Linial, M.L. The promyelocytic leukemia protein does not mediate foamy virus latencyin vitro. J. Virol. 2003, 77, 2207–2213, doi:10.1128/JVI.77.3.2207-2213.2003.
[78]
Regad, T.; Saib, A.; Lallemand-Breitenbach, V.; Pandolfi, P.P.; de The, H.; Chelbi-Alix, M.K. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J. 2001, 20, 3495–3505, doi:10.1093/emboj/20.13.3495.
[79]
Matthes, D.; Wiktorowicz, T.; Zahn, J.; Bodem, J.; Stanke, N.; Lindemann, D.; Rethwilm, A. Basic residues in the foamy virus gag protein. J. Virol. 2011, 85, 3986–3995, doi:10.1128/JVI.01906-10.
Jouvenet, N.; Neil, S.J.; Zhadina, M.; Zang, T.; Kratovac, Z.; Lee, Y.; McNatt, M.; Hatziioannou, T.; Bieniasz, P.D. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 2009, 83, 1837–1844, doi:10.1128/JVI.02211-08.
[82]
Delebecque, F.; Suspene, R.; Calattini, S.; Casartelli, N.; Saib, A.; Froment, A.; Wain-Hobson, S.; Gessain, A.; Vartanian, J.P.; Schwartz, O. Restriction of foamy viruses by APOBEC cytidine deaminases. J. Virol. 2006, 80, 605–614, doi:10.1128/JVI.80.2.605-614.2006.
[83]
Russell, R.A.; Wiegand, H.L.; Moore, M.D.; Schafer, A.; McClure, M.O.; Cullen, B.R. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J. Virol. 2005, 79, 8724–8731, doi:10.1128/JVI.79.14.8724-8731.2005.
[84]
L？chelt, M.; Romen, F.; Bastone, P.; Muckenfuss, H.; Kirchner, N.; Kim, Y.B.; Truyen, U.; Rosler, U.; Battenberg, M.; Saib, A.; et al. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. USA 2005, 102, 7982–7987, doi:10.1073/pnas.0501445102.
[85]
Pacheco, B.; Finzi, A.; McGee-Estrada, K.; Sodroski, J. Species-Specific inhibition of foamy viruses from South American monkeys by New World Monkey TRIM5{alpha} proteins. J. Virol. 2010, 84, 4095–4099, doi:10.1128/JVI.02631-09.
[86]
Yap, M.W.; Lindemann, D.; Stanke, N.; Reh, J.; Westphal, D.; Hanenberg, H.; Ohkura, S.; Stoye, J.P. Restriction of foamy viruses by primate Trim5alpha. J. Virol. 2008, 82, 5429–5439, doi:10.1128/JVI.02462-07.
[87]
De Silva, S.; Wu, L. TRIM5 acts as more than a retroviral restriction factor. Viruses 2011, 13, 1204–1209, doi:10.3390/v3071204.
[88]
Grutter, M.G.; Luban, J. TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling. Curr. Opin. Virol. 2012, 2, 142–150, doi:10.1016/j.coviro.2012.02.003.
[89]
Switzer, W.M.; Salemi, M.; Shanmugam, V.; Gao, F.; Cong, M.E.; Kuiken, C.; Bhullar, V.; Beer, B.E.; Vallet, D.; Gautier-Hion, A.; et al. Ancient co-speciation of simian foamy viruses and primates. Nature 2005, 434, 376–380, doi:10.1038/nature03341.
